Price T Rowe Associates Inc Longboard Pharmaceuticals, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,217,995 shares of LBPH stock, worth $60 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,217,995
Previous 1,626,982
36.33%
Holding current value
$60 Million
Previous $9.81 Million
388.28%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LBPH
# of Institutions
106Shares Held
30MCall Options Held
16.3KPut Options Held
56.5K-
Cormorant Asset Management, LP Boston, MA3.35MShares$90.6 Million4.17% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.94MShares$79.5 Million0.3% of portfolio
-
Wellington Management Group LLP Boston, MA2.14MShares$57.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.87MShares$50.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.72MShares$46.6 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $367M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...